SE436969B - Sett att framstella humanspecifikt interferon - Google Patents

Sett att framstella humanspecifikt interferon

Info

Publication number
SE436969B
SE436969B SE7900493A SE7900493A SE436969B SE 436969 B SE436969 B SE 436969B SE 7900493 A SE7900493 A SE 7900493A SE 7900493 A SE7900493 A SE 7900493A SE 436969 B SE436969 B SE 436969B
Authority
SE
Sweden
Prior art keywords
human
interferon
cells
human cells
animal
Prior art date
Application number
SE7900493A
Other languages
English (en)
Swedish (sv)
Other versions
SE7900493L (sv
Inventor
K Sugimoto
S Yuen
Original Assignee
Hayashibara Ken
Ashida Shin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP536878A external-priority patent/JPS5498307A/ja
Priority claimed from JP13402678A external-priority patent/JPS5562024A/ja
Application filed by Hayashibara Ken, Ashida Shin filed Critical Hayashibara Ken
Publication of SE7900493L publication Critical patent/SE7900493L/xx
Publication of SE436969B publication Critical patent/SE436969B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/91—Cell lines ; Processes using cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE7900493A 1978-01-22 1979-01-19 Sett att framstella humanspecifikt interferon SE436969B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP536878A JPS5498307A (en) 1978-01-22 1978-01-22 Production of interferon
JP13402678A JPS5562024A (en) 1978-10-31 1978-10-31 Preventive and remedy for interferon-sensitive disease

Publications (2)

Publication Number Publication Date
SE7900493L SE7900493L (sv) 1979-07-23
SE436969B true SE436969B (sv) 1985-02-04

Family

ID=26339293

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7900493A SE436969B (sv) 1978-01-22 1979-01-19 Sett att framstella humanspecifikt interferon

Country Status (14)

Country Link
US (1) US4276282A (US08066781-20111129-C00013.png)
AU (1) AU533201B2 (US08066781-20111129-C00013.png)
CA (1) CA1135186A (US08066781-20111129-C00013.png)
CH (1) CH637831A5 (US08066781-20111129-C00013.png)
DE (1) DE2902136C2 (US08066781-20111129-C00013.png)
DK (1) DK153848C (US08066781-20111129-C00013.png)
ES (1) ES477060A1 (US08066781-20111129-C00013.png)
FI (1) FI66428C (US08066781-20111129-C00013.png)
FR (1) FR2414920A1 (US08066781-20111129-C00013.png)
GB (1) GB2016015B (US08066781-20111129-C00013.png)
IT (1) IT1116493B (US08066781-20111129-C00013.png)
NL (1) NL192086C (US08066781-20111129-C00013.png)
NO (1) NO152976C (US08066781-20111129-C00013.png)
SE (1) SE436969B (US08066781-20111129-C00013.png)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5598118A (en) * 1979-01-18 1980-07-25 Hayashibara Takeshi Preparation of type-2 interferon and drug containing the same
JPS55122717A (en) * 1979-03-15 1980-09-20 Asai Gerumaniumu Kenkyusho:Kk Interferon inducer
WO1981001102A1 (en) * 1979-10-19 1981-04-30 A Romano Medicine for the treatment of viral infections of the eye and other organs
US4328207A (en) * 1979-12-27 1982-05-04 Ken Hayashibara Process for preparing mouse interferon
US4497796A (en) * 1980-03-26 1985-02-05 The Regents Of The University Of California Gene transfer in intact mammals
US4396601A (en) * 1980-03-26 1983-08-02 The Regents Of The University Of Calif. Gene transfer in intact mammals
JPS6045850B2 (ja) * 1980-12-13 1985-10-12 株式会社林原生物化学研究所 ヒト副腎皮質刺激ホルモンの製法
JPS6045848B2 (ja) * 1980-07-31 1985-10-12 株式会社林原生物化学研究所 ヒト成長ホルモンの製造方法
US4621053A (en) * 1980-07-30 1986-11-04 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for the production of human peptide hormones
JPS5825439B2 (ja) * 1980-12-30 1983-05-27 株式会社林原生物化学研究所 ヒト副甲状腺ホルモンの製造方法
JPS5826317B2 (ja) * 1980-12-30 1983-06-02 株式会社 林原生物化学研究所 ヒト甲状腺刺激ホルモンの製造方法
JPS5739795A (en) * 1980-08-22 1982-03-05 Hayashibara Biochem Lab Inc Preparation of human prolactin
JPS5825440B2 (ja) * 1980-12-30 1983-05-27 株式会社林原生物化学研究所 ヒトカルシトニンの製造方法
JPS5729294A (en) * 1980-07-30 1982-02-17 Hayashibara Biochem Lab Inc Preparation of human insulin
JPS6045851B2 (ja) * 1980-12-19 1985-10-12 株式会社林原生物化学研究所 ヒト胎盤性ラクトゲンの製造方法
US4462985A (en) * 1980-08-22 1984-07-31 University Of Illinois Foundation Delivery of biologically active components of heterologous species interferon isolates
JPS586475B2 (ja) * 1980-08-23 1983-02-04 株式会社 林原生物化学研究所 ヒト絨毛性性腺刺激ホルモンの製造方法
JPS6045849B2 (ja) * 1980-08-25 1985-10-12 林原 健 ヒトエリトロポエチンの製造方法
JPS5743696A (en) * 1980-08-27 1982-03-11 Hayashibara Biochem Lab Inc Preparation of human luteinizing hormone
JPS585671B2 (ja) * 1980-08-27 1983-02-01 株式会社 林原生物化学研究所 ヒト卵胞刺激ホルモンの製造方法
JPS5852634B2 (ja) * 1980-12-05 1983-11-24 株式会社林原生物化学研究所 ウロキナ−ゼの製造法
JPS609795B2 (ja) * 1980-12-11 1985-03-13 株式会社林原生物化学研究所 ヒト上皮細胞成長因子の製造方法
US4364863A (en) * 1980-12-29 1982-12-21 Schering Corporation Extraction of interferon from bacteria
JPS6030657B2 (ja) * 1980-12-31 1985-07-17 株式会社林原生物化学研究所 ヒト細胞増殖促進因子の製造方法
JPS6030654B2 (ja) * 1980-12-31 1985-07-17 株式会社林原生物化学研究所 ヒトコロニ−刺激因子の製造方法
FR2513124B1 (fr) * 1981-07-21 1989-11-17 Hayashibara Biochem Lab Production et applications du facteur de lyse des cellules-cibles
DE3249946C2 (de) * 1981-07-21 1996-03-21 Hayashibara Biochem Lab hTNF-haltiges therapeutisches Mittel gegen maligne Tumoren und dessen Verwendung
WO1983001198A1 (en) * 1981-10-08 1983-04-14 Kurt Frimann Berg Method and composition for treating a patient suffering from interferon-susceptible disorder
US4675295A (en) * 1981-10-28 1987-06-23 Denki Kagaku Kogyo Kabushiki Kaisha Process for producing subculturable lymphokine-producing human T cell hybridomas
JPS58126786A (ja) * 1982-01-25 1983-07-28 Hayashibara Biochem Lab Inc ヒトカリクレインの製造方法
JPS58138395A (ja) * 1982-02-12 1983-08-17 Hayashibara Biochem Lab Inc ヒト免疫応答抑制因子の製造方法
US4624917A (en) * 1982-02-17 1986-11-25 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for the production of human T-cell growth factor
US4987079A (en) * 1982-07-06 1991-01-22 Wilbur D. Smith Composition and method for in vitro cell culture
EP0116631A4 (en) * 1982-08-10 1986-04-15 Univ Columbia USE OF EUKARYOTIC ACTIVATING SEQUENCES IN THE PRODUCTION OF PROTEIN MATERIALS.
US5702699A (en) * 1982-09-23 1997-12-30 Cetus Corporation Process for the recovery of lipophilic proteins
US4870009A (en) * 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
US5910304A (en) * 1982-12-13 1999-06-08 Texas A&M University System Low-dose oral administration of interferons
US4820515A (en) * 1982-12-13 1989-04-11 Texas A&M University System Method of using interferon in low dosage to regulate appetite and efficiency of food utilization
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4489163A (en) 1983-04-14 1984-12-18 The Salk Institute For Biological Studies rCRF and analogs
DE3476634D1 (en) * 1983-06-13 1989-03-16 Ragnvald Erik Lindblom A method of treating interferon sensitive diseases, and a method and a device for preparing a _g(g)-interferon containing preparation
US4680174A (en) * 1984-05-24 1987-07-14 Damon Biotech, Inc. Induction of immune response by immunization with encapsulated antigen-producing cells
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
CA1320905C (en) * 1986-11-06 1993-08-03 Joseph M. Cummins Treatment of immuno-resistant disease
ZA878295B (en) * 1986-11-06 1988-05-03 Amarillo Cell Culture Co. Inc. Treatment of immuno-resistant disease
US5175385A (en) * 1987-09-03 1992-12-29 Ohio University/Edison Animal Biotechnolgy Center Virus-resistant transgenic mice
DE3731255A1 (de) * 1987-09-17 1989-04-06 Boehringer Ingelheim Int Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
US5017371A (en) * 1988-01-06 1991-05-21 Amarillo Cell Culture Company, Incorporated Method for reducing side effects of cancer therapy
JPH0665297A (ja) * 1992-08-21 1994-03-08 Hayashibara Biochem Lab Inc メラニン合成抑制蛋白質とその製造方法並びに用途
EP0619120B1 (en) * 1993-04-09 2002-09-11 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Use of human interferon-alpha for the manufacture of a medicament for treatment of respiratory disease in cats
US7135458B1 (en) 1995-11-15 2006-11-14 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use
JP4004088B2 (ja) 1995-09-26 2007-11-07 株式会社林原生物化学研究所 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質
US5723718A (en) * 1994-12-20 1998-03-03 St. Joseph's Hospital And Medical Center Induction of immune tolerance to tumor cells
US5939286A (en) * 1995-05-10 1999-08-17 University Of Florida Hybrid interferon tau/alpha polypeptides, their recombinant production, and methods using them
US6204022B1 (en) 1996-04-12 2001-03-20 Pepgen Corporation And University Of Florida Low-toxicity human interferon-alpha analogs
JPH1080270A (ja) * 1996-07-19 1998-03-31 Hayashibara Biochem Lab Inc ポリペプチドをプロセッシングする酵素
TW515843B (en) * 1996-07-25 2003-01-01 Hayashibara Biochem Lab Process for producing an active polypeptide inducing interferon-γ production
US6514728B1 (en) * 1998-11-09 2003-02-04 Nippon Biocaptal Limited Process for preparation of cytokines using Sendai virus expression system
EP1092773A3 (en) * 1999-10-15 2001-08-08 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Polypeptide and uses thereof
JP2002201141A (ja) 2000-10-27 2002-07-16 Hayashibara Biochem Lab Inc 蛋白質合成抑制遺伝子の発現増強剤
WO2003016472A2 (en) * 2001-08-12 2003-02-27 Pepgen Corporation Hybrid interferon/interferon tau proteins, compositions and methods of use
US20160106813A1 (en) 2013-03-29 2016-04-21 Centre National De La Recherche Schientifique (Cnrs) Cgrp receptor agonist for hiv treatment or prevention
WO2015140348A2 (en) 2014-03-21 2015-09-24 Centre National De La Recherche Scientifique (Cnrs) Use of dj-1 deglycase activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR6914761D0 (pt) * 1969-01-17 1973-03-08 Merck & Co Inc Processos quimicos

Also Published As

Publication number Publication date
AU533201B2 (en) 1983-11-10
FI66428C (fi) 1984-10-10
NL192086B (nl) 1996-10-01
NO152976C (no) 1985-12-27
ES477060A1 (es) 1979-12-16
DE2902136C2 (de) 1986-09-04
GB2016015B (en) 1982-05-06
SE7900493L (sv) 1979-07-23
GB2016015A (en) 1979-09-19
FR2414920A1 (fr) 1979-08-17
CA1135186A (en) 1982-11-09
NO152976B (no) 1985-09-16
NL7900476A (nl) 1979-07-24
DE2902136A1 (de) 1979-08-09
FI790188A (fi) 1979-07-23
NL192086C (nl) 1997-02-04
IT1116493B (it) 1986-02-10
IT7947712A0 (it) 1979-01-19
FR2414920B1 (US08066781-20111129-C00013.png) 1982-08-06
AU4334579A (en) 1979-08-02
US4276282A (en) 1981-06-30
NO790195L (no) 1979-07-24
DK25579A (da) 1979-07-23
DK153848B (da) 1988-09-12
DK153848C (da) 1989-04-03
CH637831A5 (fr) 1983-08-31
FI66428B (fi) 1984-06-29

Similar Documents

Publication Publication Date Title
SE436969B (sv) Sett att framstella humanspecifikt interferon
DK169479B1 (da) Fremgangsmåde til fremstilling af humanspecifikt type II-interferon
KR930000188B1 (ko) 신규 림포카인(lymphokine), 이 림포카인에 특이적인 모노클로날 항체 및 이들의 제조방법
JPS6227048B2 (US08066781-20111129-C00013.png)
US4328207A (en) Process for preparing mouse interferon
JPS5852634B2 (ja) ウロキナ−ゼの製造法
NO173144B (no) Fremgangsmaate til fremstilling av interferongamma
JPS6011890B2 (ja) ツモアネクロシスフアクタ−の製造方法
JPH0214039B2 (US08066781-20111129-C00013.png)
JP2926409B2 (ja) 癌転移抑制因子の製造方法
KR820001174B1 (ko) 사람 특이성 인터페론의 제조법
KR830001817B1 (ko) 타이프ⅱ 인터페론의 제조방법
KR970002165B1 (ko) γ-인터페론의 제조방법과 그 용도
JPS61263929A (ja) 抗タイプ２インターフェロン感受性疾患剤
JPS5888322A (ja) 標的細胞障害性因子を含有する悪性腫瘍治療剤とその製造方法
JP2850293B2 (ja) γ−インターフェロン感受性疾患剤
JPS5815921A (ja) 抗リンホトキシン感受性疾患剤
JPS58320B2 (ja) マウスインタ−フエロンの製造方法
GB2118560A (en) Process for producing human Immune Response Suppressor
JPS6267026A (ja) 新リンホカインｉｉｉとその製法
JPH0526468B2 (US08066781-20111129-C00013.png)
JPS61115026A (ja) 新リンホカイン２の製造方法
JPS61115027A (ja) 新リンホカイン２とその製法および用途
Jensen The effect of phytohemagglutinin on vaccinia replication in vitro.
JPS61115099A (ja) モノクロ−ナル抗体とその製法

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7900493-3

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7900493-3

Format of ref document f/p: F